Purinergic receptor regulation of LPS-induced signaling and pathophysiology

Journal of Endotoxin Research

Volumn 9, Issue 4, 2003, Pages 256-263

  Guerra, Alma N ^a   Fisette, Philip L ^a   Pfeiffer, Zachary A ^a   Quinchia Rios, Beatriz H ^a   Prabhu, Usha ^a   Aga, Mini ^a   Denlinger, Loren C ^a   Guadarrama, Arturo G ^a   Abozeid, Sara ^a   Sommer, Julie A ^a   Proctor, Richard A ^a   Bertics, Paul J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE TRIPHOSPHATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; NITRIC OXIDE; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; PURINE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IN VIVO STUDY; MACROPHAGE; MALE; MONOCYTE; MORTALITY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADENOSINE TRIPHOSPHATE; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; HUMANS; INTERLEUKIN-1; LIGANDS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN BINDING; RECEPTORS, PURINERGIC P2; SHOCK, SEPTIC; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 10744223451     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805103225001468     Document Type: Article

References (22)

1. Abraham E, Matthay MA, Dinarello CA et al. Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med 2000; 28: 232-235.
2. Bellingan G. Inflammatory cell activation in sepsis. Br Med Bull 1999; 55: 12-29.
3. Denlinger LC, Proctor RA. Potential risk factors for developing apoptosis during septic shock. Crit Care Med 2000; 28: 2133-2134.
4. Beutler B. Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol 2000; 12: 20-26.
5. 7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J Immunol 2001; 167: 1871-1876.
6. Tanke T, van de Loo JW, Rhim H, Leventhal PS, Proctor RA, Bertics PJ. Bacterial lipopolysaccharide-stimulated GTPase activity in RAW 264.7 macrophage membranes. Biochem J 1991; 277: 379-385.
7. Proctor RA, Denlinger LC, Leventhal PS et al. Protection of mice from endotoxic death by 2-methylthio-ATP. Proc Natl Acad Sci USA 1994; 91: 6017-6020.
8. Di Virgilio F, Chiozzi P, Ferrari D et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 2001; 97: 587-600.
9. 7 nucleotide receptor: modulation of LPS-induced macrophage signaling and mediator production. Drug Dev Res 2001; 53: 91-104.
10. Sak K, Webb TE. A retrospective of recombinant P2Y receptor subtypes and their pharmacology. Arch Biochem Biophys 2002; 397: 131-136.
11. Khakh BS, Burnstock G, Kennedy C et al. International Union of Pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 2001; 53: 107-118.
12. Dubyak GR, Clifford EE, Humphreys BD, Kertesy SB, Martin KA. Expression of multiple ATP receptor subtypes during the differentiation and inflammatory activation of myeloid leukocytes. Drug Dev Res 1996; 39: 269-278.
13. Burnstock G. Overview of P2 receptors: possible functions in immune cells. Drug Dev Res 2001; 53: 53-59.
14. Hu Y, Fisette PL, Denlinger LC et al. Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages. J Biol Chem 1998; 273: 27170-27175.
15. Denlinger LC, Fisette PL, Garis KA et al. Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem 1996; 271: 337-342.
16. Sommer JA, Fisette PL, Hu Y et al. Purinergic receptor modulation of LPS-stimulated signaling events and nitric oxide release in RAW 264.7 macrophages. J Endotoxin Res 1999; 5: 70-74
17. 7-independent mechanism. J Immunol 1999; 163: 558-561.
18. 7 nucleotide receptor in lipopolysaccharide-stimulated macrophage activation. PhD Thesis, 1999; University of Wisconsin-Madison, USA.
19. Boarder MR, Hourani SMO The regulation of vascular function by P2 receptors: multiple sites and multiple receptors. Trends Pharmacol Sci 1998; 19: 99-107.
20. Warny M, Aboudola S, Robson SC et al. P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide. J Biol Chem 2001; 276: 26051-26056.
21. Perregaux DG, McNiff P, Laliberte R, Conklyn M, Gabel CA. ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood. J Immunol 2000; 165: 4615-4623.
22. Solle M, Labasi J, Perregaux DG et al. Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 2001; 276: 125-132.